{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:13:15Z","timestamp":1790061195599,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ibroneuroscience.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.neuroscience.2007.10.062","type":"journal-article","created":{"date-parts":[[2008,1,11]],"date-time":"2008-01-11T11:03:15Z","timestamp":1200049395000},"page":"429-436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["Developmental regulation of leucine-rich repeat kinase 1 and 2 expression in the brain and other rodent and human organs: Implications for Parkinson\u2019s disease"],"prefix":"10.1016","volume":"152","author":[{"given":"M.","family":"Westerlund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.C.","family":"Belin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Anvret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bickford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Galter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2007.10.062_bib1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.parkreldis.2005.07.005","article-title":"Alterations of T-lymphocyte populations in Parkinson disease","volume":"11","author":"Baba","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib2","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1093\/brain\/awh666","article-title":"Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson\u2019s disease","volume":"128","author":"Berg","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib3","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1093\/brain\/awh676","article-title":"Genetics of Parkinson\u2019s disease: LRRK2 on the rise","volume":"128","author":"Brice","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00716936","article-title":"Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry","volume":"98","author":"Dagerlind","year":"1992","journal-title":"Histochemistry"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib5","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nrg1831","article-title":"Genetics of Parkinson disease: paradigm shifts and future prospects","volume":"7","author":"Farrer","year":"2006","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ana.10113","article-title":"A new locus for Parkinson\u2019s disease (PARK8) maps to chromosome 12p11.2-q13.1","volume":"51","author":"Funayama","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib7","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.20808","article-title":"LRRK2 expression linked to dopamine-innervated areas","volume":"59","author":"Galter","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jemt.1060100305","article-title":"Synaptic organization of the striatum","volume":"10","author":"Gerfen","year":"1988","journal-title":"J Electron Microsc Tech"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ana.20791","article-title":"Biochemical and pathological characterization of Lrrk2","volume":"59","author":"Giasson","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/hmg\/ddi439","article-title":"The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity","volume":"15","author":"Gloeckner","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib11","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/01.HYP.0000188052.69549.e4","article-title":"Neurocirculatory abnormalities in Parkinson disease with orthostatic hypotension: independence from levodopa treatment","volume":"46","author":"Goldstein","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib12","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1212\/01.wnl.0000268696.57912.64","article-title":"Neurocirculatory and nigrostriatal abnormalities in Parkinson disease from LRRK2 mutation","volume":"69","author":"Goldstein","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.nbd.2006.04.001","article-title":"Kinase activity is required for the toxic effects of mutant LRRK2\/dardarin","volume":"23","author":"Greggio","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1471-4159.2007.04523.x","article-title":"Mutations in LRRK2\/dardarin associated with Parkinson disease are more toxic than equivalent mutations in the homologous kinase LRRK1","volume":"102","author":"Greggio","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib15","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/hmg\/ddm013","article-title":"Leucine-rich repeat kinase 2 associates with lipid rafts","volume":"16","author":"Hatano","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.neulet.2007.02.020","article-title":"Variants in the LRRK1 gene and susceptibility to Parkinson\u2019s disease in Norway","volume":"416","author":"Haugarvoll","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.brainres.2007.04.034","article-title":"Localization of Parkinson\u2019s disease-associated LRRK2 in normal and pathological human brain","volume":"1155","author":"Higashi","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1471-4159.2006.04246.x","article-title":"Expression and localization of Parkinson\u2019s disease-associated leucine-rich repeat kinase 2 in the mouse brain","volume":"100","author":"Higashi","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib19","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.cellsig.2005.08.015","article-title":"LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain","volume":"18","author":"Korr","year":"2006","journal-title":"Cell Signal"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib20","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1093\/molbev\/msl114","article-title":"The Parkinson disease gene LRRK2: evolutionary and structural insights","volume":"23","author":"Marin","year":"2006","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib21","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.neuroscience.2006.01.017","article-title":"Anatomical localization of leucine-rich repeat kinase 2 in mouse brain","volume":"139","author":"Melrose","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib22","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.neuroscience.2007.05.027","article-title":"A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body disease","volume":"147","author":"Melrose","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib23","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/01.jnen.0000235121.98052.54","article-title":"LRRK2 expression in normal and pathologic human brain and in human cell lines","volume":"65","author":"Miklossy","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF00519099","article-title":"Early prenatal ontogeny of central monoamine neurons in the rat: fluorescence histochemical observations","volume":"137","author":"Olson","year":"1972","journal-title":"Z Anat Entwicklungsgesch"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease","volume":"44","author":"Paisan-Ruiz","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib26","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.20731","article-title":"Lrrk2 and Lewy body disease","volume":"59","author":"Ross","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00525058","article-title":"Late prenatal ontogeny of central monoamine neurons in the rat: Fluorescence histochemical observations","volume":"140","author":"Seiger","year":"1973","journal-title":"Z Anat Entwicklungsgesch"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib29","doi-asserted-by":"crossref","first-page":"18676","DOI":"10.1073\/pnas.0508052102","article-title":"Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration","volume":"102","author":"Smith","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10048-006-0075-8","article-title":"Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson\u2019s disease","volume":"8","author":"Taylor","year":"2007","journal-title":"Neurogenetics"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib31","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1471-4159.2006.03919.x","article-title":"Distribution of PINK1 and LRRK2 in rat and mouse brain","volume":"98","author":"Taymans","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib32","doi-asserted-by":"crossref","first-page":"16842","DOI":"10.1073\/pnas.0507360102","article-title":"Parkinson\u2019s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity","volume":"102","author":"West","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib33","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1212\/01.WNL.0000125015.06989.DB","article-title":"Autosomal dominant parkinsonism associated with variable synuclein and tau pathology","volume":"62","author":"Wszolek","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib34","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2007.10.062_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1086\/380647","article-title":"The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval","volume":"74","author":"Zimprich","year":"2004","journal-title":"Am J Hum Genet"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452208000109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452208000109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T12:42:19Z","timestamp":1719405739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452208000109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0306452208000109"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2007.10.062","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developmental regulation of leucine-rich repeat kinase 1 and 2 expression in the brain and other rodent and human organs: Implications for Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2007.10.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 IBRO. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}